Considers all clinical studies without distinction of their status. Also counts completed, no longer available, suspended, terminated and withdrawn trials.
As of February 2025, there was a total of COVID-19-related clinical trials carried out in Ecuador: *** of them in Phase * and *** in Phase *. In 2024, over a million cases of COVID19 were reported in the South American country.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
ClinicalTrials.gov. (February 28, 2025). Number of registered clinical studies in Ecuador for COVID-19 as of February 2025, by phase [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 23, 2026, from /statistics/1560177/ecuador-clinical-trials-phase-covid/
ClinicalTrials.gov. "Number of registered clinical studies in Ecuador for COVID-19 as of February 2025, by phase." Chart. February 28, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 23, 2026. /statistics/1560177/ecuador-clinical-trials-phase-covid/
ClinicalTrials.gov. (2025). Number of registered clinical studies in Ecuador for COVID-19 as of February 2025, by phase. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 23, 2026. /statistics/1560177/ecuador-clinical-trials-phase-covid/
ClinicalTrials.gov. "Number of Registered Clinical Studies in Ecuador for Covid-19 as of February 2025, by Phase." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 28 Feb 2025, /statistics/1560177/ecuador-clinical-trials-phase-covid/
ClinicalTrials.gov, Number of registered clinical studies in Ecuador for COVID-19 as of February 2025, by phase ÌÇÐÄÆƽâ°æ, /statistics/1560177/ecuador-clinical-trials-phase-covid/ (last visited July 23, 2026)
Number of registered clinical studies in Ecuador for COVID-19 as of February 2025, by phase [Graph], ClinicalTrials.gov, February 28, 2025. [Online]. Available: /statistics/1560177/ecuador-clinical-trials-phase-covid/
